Ocuphire Pharma Inc (OCUP)
1.29
-0.01
(-0.77%)
USD |
NASDAQ |
Sep 27, 16:00
1.29
0.00 (0.00%)
After-Hours: 20:00
Ocuphire Pharma Accounts Payable (Quarterly): 0.634M for June 30, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 0.634M |
March 31, 2024 | 2.064M |
December 31, 2023 | 2.153M |
September 30, 2023 | 1.89M |
June 30, 2023 | 2.323M |
March 31, 2023 | 2.221M |
December 31, 2022 | 1.069M |
September 30, 2022 | 1.468M |
Date | Value |
---|---|
June 30, 2022 | 1.886M |
March 31, 2022 | 1.579M |
December 31, 2021 | 1.584M |
September 30, 2021 | 1.434M |
June 30, 2021 | 1.496M |
March 31, 2021 | 1.415M |
December 31, 2020 | 1.214M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.634M
Minimum
Jun 2024
2.323M
Maximum
Jun 2023
1.629M
Average
1.579M
Median
Mar 2022
Accounts Payable (Quarterly) Benchmarks
Baxter International Inc | 1.251B |
Syros Pharmaceuticals Inc | 7.469M |
Elanco Animal Health Inc | 291.00M |
NovaBay Pharmaceuticals Inc | 1.235M |
Palatin Technologies Inc | 3.443M |